October 29, 2020

The Niche

Knoepfler lab stem cell blog

stem cell therapies

3 min read

One of the biggest stem cell news stories of 2016 has been the REGROW Act, a bill intended to accelerate investigational stem cell and regenerative medicine therapies to patients by lessening FDA oversight, but in the last couple months REGROW has mostly disappeared from the news. Will REGROW do a reappearing act like some kind of magician? REGROW is in fact still out there so it is not gone by any means. Republican senators have been discussing including REGROW in a large medical spending bill …Read More

4 min read

What should the stem cell field try to do about cowboy stem cell clinics? By this term I mean those that don’t follow the rules. They shoot stem cells into customers first and ask questions later. I’ve interacted with many patients over the years who are interested in stem cells. This interaction is growing much more frequent. I enjoy interacting with them and have learned a lot this way, but I am often faced with dilemmas. These patients may be facing fatal illnesses or …Read More

6 min read

Many patients ask me what questions they should be asking doctors and stem cell clinics about possible stem cell therapies. Here is my top 10 list of key items (in both graphic summarized form and detailed text form) that you need to know about and questions about a potential stem cell therapy. Some of these questions are indeed probing, but that’s appropriate when you consider these folks may inject stem cells in your body, a therapy that may never go away completely. It’s not …Read More

3 min read

Businessweek just published a very long, interesting article on Celltex by Susan Berfield yesterday. I was happy to talk with Susan at length about the key issues and be quoted in the article. See image at left of two key Celltex leaders, David Eller, CEO of Celltex, and Stan Jones above (Photograph by Thomas Prior for Bloomberg Businessweek). On the positive side, I think the article sheds significant light on Celltex and its former partner RNL Bio/Human Biostar. It also provides the perspectives of …Read More